[
    [
        {
            "time": "",
            "original_text": "康为世纪冲刺科创板：研发费用占比逐年降低 华大基因曾连续三年是第一大客户",
            "features": {
                "keywords": [
                    "康为世纪",
                    "科创板",
                    "研发费用",
                    "占比逐年降低",
                    "华大基因",
                    "第一大客户"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康为世纪冲刺科创板：研发费用占比逐年降低 华大基因曾连续三年是第一大客户",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]